#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Inclusion body myositis Small intestine neuroendocrine tumour Vulval cancer recurrent Hypotransferrinaemia Marginal zone lymphoma recurrent Gestational trophoblastic tumour Glomerulonephritis Rhabdoid tumour Autoimmune haemolytic anaemia Follicular lymphoma stage III Philadelphia positive acute lymphocytic leukaemia Chronic myeloid leukaemia (in remission) Small cell lung cancer Sickle cell anaemia Neurodevelopmental disorder More trials…

    Learn about Rare Diseases

    Lymphangiosarcoma – Treatment Nodal marginal zone B-cell lymphoma Behcet’s syndrome – Treatment Bronchopulmonary dysplasia – Diagnostics Netherton’s syndrome – Basic Information Paraneoplastic neurological syndrome – Diagnostics Sarcoidosis – Diagnostics IgA nephropathy – Diagnostics Mantle cell lymphoma refractory Metachromatic leukodystrophy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Stiripentol Englumafusp Alfa Platelet Concentrate Thiotepa Rimegepant IMB 101 Pabinafusp Alfa Brexpiprazole Fumarate Cimetidine Hydrochloride Timrepigene Emparvovec Spiramycin Octreotide Hydrochloride Falbikitug Ptc518 Brimonidine Pegvaliase Sodium Laurilsulfate Prasterone Crisantaspase Vonafexor More therapies…

    Learn about Your Condition

    Endometrial cancer stage IV Intestinal ischaemia Vaginal haemorrhage H1N1 influenza Polymyositis Plasma cell myeloma refractory Back pain Knee arthroplasty Iron deficiency Ebola disease Hyperinsulinism Leukoencephalopathy Muscle hypertrophy Diminished ovarian reserve Choroidal dystrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Non-small cell lung cancer stage III

  • Study of radiotherapy with durvalumab and ceralasertib in patients with stage III non-small cell lung cancer who have thoracic relapse after PACIFIC treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Ceralasertib
    • Durvalumab
    Italy

  • Study of sacituzumab govitecan and zimberelimab treatment before and after surgery for patients with resectable non-small cell lung cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Sacituzumab Govitecan
    • Zimberelimab
    Germany

  • Study on Thoracic Radiotherapy and Durvalumab for Elderly or Frail Stage III Non-Small Cell Lung Cancer Patients Unable to Undergo Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    • Non-small cell lung cancer stage IIIA
    • Non-small cell lung cancer stage IIIB
    Investigated Drugs:
    • Durvalumab
    Germany

  • Study on Sotorasib for Patients with Advanced KRAS G12C-Mutated Non-Small Cell Lung Cancer and Comorbidities

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Sotorasib
    Denmark Norway Sweden

  • Study of Atezolizumab for Patients with Advanced Non-Small Cell Lung Cancer After Chemotherapy and Radiation Therapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Atezolizumab
    Slovenia Spain

  • Study on Osimertinib and Drug Combination for Adults with Unresectable Non-small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Osimertinib
    • Carboplatin
    • Cisplatin
    Spain
Previous Page
1 2 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!